Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1792.09 | 576 / 578 | 92% | 19.81 | 1061 / 1155 |
skin | 91% | 1457.11 | 1639 / 1809 | 96% | 77.03 | 452 / 472 |
breast | 82% | 689.72 | 377 / 459 | 81% | 14.38 | 906 / 1118 |
stomach | 72% | 354.00 | 257 / 359 | 84% | 15.46 | 240 / 286 |
intestine | 57% | 873.49 | 555 / 966 | 81% | 12.82 | 428 / 527 |
esophagus | 43% | 199.80 | 619 / 1445 | 91% | 27.34 | 167 / 183 |
uterus | 36% | 154.99 | 61 / 170 | 92% | 24.41 | 421 / 459 |
bladder | 57% | 338.43 | 12 / 21 | 58% | 8.83 | 290 / 504 |
prostate | 73% | 357.19 | 180 / 245 | 40% | 3.12 | 199 / 502 |
kidney | 38% | 231.82 | 34 / 89 | 73% | 12.25 | 660 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 95.54 | 29 / 29 |
spleen | 100% | 6436.92 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 11235.37 | 927 / 929 | 0% | 0 | 0 / 0 |
thymus | 58% | 324.15 | 381 / 653 | 40% | 5.85 | 241 / 605 |
tonsil | 0% | 0 | 0 / 0 | 98% | 46.68 | 44 / 45 |
ovary | 8% | 29.65 | 14 / 180 | 82% | 25.88 | 353 / 430 |
adipose | 89% | 542.86 | 1071 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 7% | 26.79 | 24 / 328 | 74% | 11.62 | 132 / 178 |
blood vessel | 78% | 426.45 | 1040 / 1335 | 0% | 0 | 0 / 0 |
liver | 54% | 200.98 | 122 / 226 | 23% | 2.26 | 94 / 406 |
adrenal gland | 34% | 99.47 | 88 / 258 | 9% | 0.68 | 21 / 230 |
eye | 0% | 0 | 0 / 0 | 41% | 7.68 | 33 / 80 |
brain | 10% | 35.29 | 277 / 2642 | 28% | 2.29 | 197 / 705 |
heart | 13% | 44.48 | 110 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 2.95 | 8 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043371 | Biological process | negative regulation of CD4-positive, alpha-beta T cell differentiation |
GO_0030097 | Biological process | hemopoiesis |
GO_0045786 | Biological process | negative regulation of cell cycle |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0002062 | Biological process | chondrocyte differentiation |
GO_0071559 | Biological process | response to transforming growth factor beta |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0030182 | Biological process | neuron differentiation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043378 | Biological process | positive regulation of CD8-positive, alpha-beta T cell differentiation |
GO_0045595 | Biological process | regulation of cell differentiation |
GO_0048935 | Biological process | peripheral nervous system neuron development |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0001503 | Biological process | ossification |
GO_0006468 | Biological process | protein phosphorylation |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016513 | Cellular component | core-binding factor complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RUNX3 |
Protein name | Runt-related transcription factor 3 (Acute myeloid leukemia 2 protein) (Core-binding factor subunit alpha-3) (CBF-alpha-3) (Oncogene AML-2) (Polyomavirus enhancer-binding protein 2 alpha C subunit) (PEA2-alpha C) (PEBP2-alpha C) (SL3-3 enhancer factor 1 alpha C subunit) (SL3/AKV core-binding factor alpha C subunit) |
Synonyms | AML2 CBFA3 PEBP2A3 |
Description | FUNCTION: Forms the heterodimeric complex core-binding factor (CBF) with CBFB. RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'-TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. The heterodimers bind to the core site of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL3 and GM-CSF promoters (By similarity). May be involved in the control of cellular proliferation and/or differentiation. In association with ZFHX3, up-regulates CDKN1A promoter activity following TGF-beta stimulation . CBF complexes repress ZBTB7B transcription factor during cytotoxic (CD8+) T cell development. They bind to RUNX-binding sequence within the ZBTB7B locus acting as transcriptional silencer and allowing for cytotoxic T cell differentiation. CBF complexes binding to the transcriptional silencer is essential for recruitment of nuclear protein complexes that catalyze epigenetic modifications to establish epigenetic ZBTB7B silencing (By similarity). . |
Accessions | Q13761 ENST00000308873.11 [Q13761-1] ENST00000399916.5 [Q13761-2] ENST00000338888.4 [Q13761-2] |